Detection and genetic characterization of the GP60 Gene of Cryptosporidium parvum isolated from HIV(+)/AIDS patients - Kurdistan Province, Northwest Iran: predominance of subtype IId

对从伊朗西北部库尔德斯坦省 HIV(+)/AIDS 患者中分离的隐孢子虫(Cryptosporidium parvum)GP60 基因进行检测和遗传特征分析:以 IId 亚型为主

阅读:1

Abstract

BACKGROUND: Cryptosporidium spp. is an important intestinal protozoan parasite causing morbidity and mortality in immunocompromised patients, particularly those with HIV(+)/AIDS. A cross-sectional study was conducted on 161 HIV(+)/AIDS patients in Kurdistan Province, Iran, aiming to assess prevalence and genetic diversity of Cryptosporidium spp. among HIV(+)/AIDS patients. METHODS: Stool samples were examined microscopically and by nested PCR targeting the GP60 gene. PCR-positive samples were sequenced, and phylogenetic analyses were conducted using MEGA12 software. RESULTS: Of 161 faecal samples from HIV(+)/AIDS patients, seven (4.34%) and four (2.48%) positive samples were detected by PCR and microscopy, respectively (OR = 1.94, P = 0.536). Two factors showed a statistically significant association with a higher risk of Cryptosporidium infection, including using untreated drinking water and contact with animals. Patients using untreated water had a 30% infection rate, compared to 2.6% for those using purified water (OR = 15.19, P = 0.011). Patients with animal contact had a 33.3% infection rate, compared to 3.2% for those without animal contact (OR = 14.73, P = 0.047). No significant association was found with the patient's sex or urban/rural location. All isolates belonged to the C. parvum IId subtype. Phylogenetic analyses clustered all isolates within the IId clade, which are closely related to animal-derived subtypes. CONCLUSION: The genetic similarity with previously reported animal isolates raises the possibility of zoonotic transmission; however, in the absence of animal or environmental sampling, this hypothesis remains speculative and should be interpreted with caution. These findings highlight the need for screening of Cryptosporidium among vulnerable populations, especially HIV(+)/AIDS patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。